Nearly a quarter of all newly-diagnosed patients with advanced lung cancer are not given a test that could improve their chances for long-term survival and reduce their side effects.

A new treatment option, Datroway (datopotamab deruxtecan or Dato-DXd), is now available for people with non-small cell lung ...

When small-cell lung cancer (SCLC) has spread to distant parts of the body, it’s classified as extensive-stage, which applies ...

A recent study reveals a direct link between air pollution and lung cancer, identifying increased DNA mutations in ...

Glenmark Pharmaceuticals has launched the lung cancer drug Tevimbra in India after approval by the Central Drugs Standard Control Organisation. Developed by global oncology leader BeiGene, now BeOne ...